How should first trimester bleeding be evaluated and managed in the clinic?

First Trimester Bleeding: Clinic Evaluation and Management

Obtain pelvic ultrasound (preferably transvaginal) immediately for all clinically stable patients presenting with first trimester bleeding, regardless of β-hCG level, as ectopic pregnancy can occur at any β-hCG value and rupture has been documented even at very low levels 1.

Initial Assessment

Vital Signs and Hemodynamic Status

• Check blood pressure, heart rate, and orthostatic vital signs to identify hemodynamic instability
• Unstable patients require immediate surgical consultation and transfer to emergency setting

Critical History Elements

• Bleeding characteristics: Amount (spotting vs. pad-soaking), duration, presence of clots or tissue passage
• Pain: Location, severity, radiation to shoulder (suggests hemoperitoneum)
• Last menstrual period: Calculate gestational age
• Risk factors for ectopic pregnancy: Prior ectopic, tubal surgery, pelvic inflammatory disease, IUD use, infertility treatment
• Pregnancy symptoms: Nausea, vomiting, breast tenderness (their presence is prognostically favorable)

Physical Examination

• Abdominal exam: Peritoneal signs, rebound tenderness (suggests rupture)
• Speculum exam: Visualize bleeding source (cervical vs. uterine), assess amount, identify cervical polyps or lacerations, check cervical os (open vs. closed)
• Bimanual exam: Uterine size consistency with dates, adnexal masses or tenderness, cervical motion tenderness

Critical caveat: Avoid digital pelvic examination until ultrasound excludes placenta previa if bleeding is heavy 2.

Diagnostic Workup

Laboratory Tests

• Quantitative β-hCG: Baseline value for serial monitoring if needed
• Blood type and Rh status: Essential for Rh immunoglobulin administration
• Complete blood count: Assess for anemia from blood loss
• Progesterone level: Optional; levels >25 ng/mL suggest viable pregnancy, <5 ng/mL suggests nonviable pregnancy

Ultrasound Protocol 3, 4

Transvaginal ultrasound is the gold standard and should include:

1. Uterine evaluation:

   • Gestational sac mean diameter (MSD)
   • Yolk sac presence (should be visible when MSD >8 mm)
   • Embryo/fetal pole presence (should be visible when MSD >16 mm)
   • Crown-rump length (CRL) measurement
   • Cardiac activity (should be present when CRL >5-7 mm)
   • Endometrial thickness and appearance

2. Adnexal evaluation:

   • Both ovaries and surrounding structures
   • Look for extraovarian masses, tubal ring sign
   • Corpus luteum (moves with ovary vs. ectopic mass)

3. Free fluid assessment:

   • Small amount in cul-de-sac is physiologic
   • Large volume or complex fluid suggests hemoperitoneum from ectopic rupture

Diagnostic Interpretation

Intrauterine Pregnancy (IUP) Confirmed

• Viable IUP: Gestational sac with yolk sac and embryo with cardiac activity

  • Management: Reassurance, pelvic rest (though evidence for benefit is limited), follow-up in 1-2 weeks
  • Prognosis: If cardiac activity present, 90-95% will continue successfully
  • Do NOT continue serial β-hCG monitoring once viable IUP confirmed 1

• Threatened abortion: Viable IUP with bleeding

  • Same management as viable IUP
  • Progesterone supplementation has insufficient evidence for benefit 5, 6
  • Bed rest does NOT improve outcomes 6

Failed IUP (Pregnancy Loss) 4

Diagnostic criteria (use most conservative to avoid harming viable pregnancy):

• Gestational sac MSD ≥25 mm without embryo, OR
• Embryo CRL ≥7 mm without cardiac activity, OR
• No embryo with heartbeat ≥11 days after scan showing gestational sac and yolk sac, OR
• No embryo with heartbeat ≥14 days after scan showing gestational sac without yolk sac

Management options (shared decision-making):

1. Expectant management: Wait for spontaneous passage (70-80% complete within 2 weeks)
2. Medical management: Misoprostol 800 mcg vaginally, repeat in 24-48 hours if needed
3. Surgical management: Uterine aspiration/D&C

Pregnancy of Unknown Location (PUL)

Definition: Positive pregnancy test but no IUP or ectopic pregnancy visible on ultrasound

Management algorithm 1:

1. If β-hCG <1,500-2,000 mIU/mL (discriminatory threshold):

   • Repeat β-hCG in 48 hours
   • Normal IUP: β-hCG rises ≥80% (some use ≥53%)
   • Abnormal pregnancy: β-hCG rises <53% or plateaus/declines
   • Repeat ultrasound when β-hCG exceeds discriminatory threshold

2. If β-hCG >discriminatory threshold without visible IUP:

   • High suspicion for ectopic pregnancy or early pregnancy loss
   • Consider methotrexate vs. surgical management vs. close observation based on clinical stability

Ectopic Pregnancy 4, 6

Ultrasound findings:

• Extraovarian adnexal mass (most common)
• Tubal ring sign (thick echogenic ring, 100% specific if yolk sac present)
• Empty uterus with β-hCG >discriminatory threshold
• Free pelvic fluid (especially if complex/large volume)

Management options:

1. Medical: Methotrexate (single or multi-dose protocol)

   • Criteria: Hemodynamically stable, β-hCG typically <5,000 mIU/mL, no cardiac activity, mass <3.5-4 cm, patient reliable for follow-up

2. Surgical: Laparoscopic salpingostomy or salpingectomy

   • Indicated for: Hemodynamic instability, contraindications to methotrexate, patient preference, failed medical management

3. Expectant: Only if β-hCG declining and patient asymptomatic

Rh Immunoglobulin Administration 7, 1

Administer 50 mcg (or 300 mcg if >12 weeks) anti-D immunoglobulin to all Rh-negative women with:

• Documented pregnancy loss (complete or incomplete abortion)
• Ectopic pregnancy

Insufficient evidence but consider for:

• Threatened abortion with heavy bleeding or pain
• Threatened abortion near 12 weeks gestation

Follow-up

• Viable IUP: Recheck in 1-2 weeks for reassurance ultrasound
• PUL: Serial β-hCG every 48 hours until diagnosis clear
• Expectant management of loss: Weekly β-hCG until <5 mIU/mL, return precautions for heavy bleeding or fever
• Post-methotrexate: β-hCG on days 4 and 7, then weekly until <5 mIU/mL

Red Flags Requiring Immediate Intervention

• Hemodynamic instability (hypotension, tachycardia)
• Severe abdominal pain with peritoneal signs
• Shoulder pain (diaphragmatic irritation from hemoperitoneum)
• Large volume or complex free fluid on ultrasound
• β-hCG >discriminatory threshold without visible IUP in unstable patient